Publications

Found 9 results
Author Title Type [ Year(Asc)]
Filters: Author is Lukin, Dana J  [Clear All Filters]
2021
De A, Chen W, Li H, Wright JR, Lamendella R, Lukin DJ, Szymczak WA, Sun K, Kelly L, Ghosh S et al..  2021.  Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.. Gastroenterology. 161(1):211-224.
Kumar A, Teslova T, Taub E, Miller JD, Lukin DJ.  2021.  Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.. Dig Dis Sci. 66(6):2005-2013.
Li H, Illés P, Karunaratne CV, Nordstrøm LUlrik, Luo X, Yang A, Qiu Y, Kurland IJ, Lukin DJ, Chen W et al..  2021.  Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimics.. Bioorg Chem. 109:104661.
Ahmed W, Lukin DJ.  2021.  Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance. Inflamm Bowel Dis. 27(6):787-790.
Charilaou P, Tricarico C, Battat R, Scherl EJ, Longman RS, Lukin DJ.  2021.  Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination.. Clin Gastroenterol Hepatol.
Lukin DJ, Funez-dePagnier G, Lima S, Lai D, Duenas-Bianchi L, Ahmed W, Jacob V, Battat R, Scherl E, Longman RS.  2021.  No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.. Clin Gastroenterol Hepatol. 19(11):2312-2314.e3.
Kumar A, Magro C, Lukin DJ.  2021.  Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease.. Gastroenterology. 160(3):e3-e5.
Ahmed W, Lukin DJ.  2021.  A step towards informed positioning of advanced therapies for moderate-to-severe Crohn's disease.. Lancet Gastroenterol Hepatol. 6(12):973-975.